FEATURED TODAY · AI & ML
Arpita Saxena, Frontier Signal — 20 August 2026
A law firm recently filed case citations produced by AI. The cases did not exist. The result was a $31,100 sanction, disciplinary charges against the lawyer, and the threat of a suspended license.
That one incident explains a lot about where roughly $2.2bn of vertical AI venture capital has gone, and why it stays there. The question buyers now ask first is not whether the market is big. It is who gets sued when the system is wrong.
Here is what happened
Four verticals are absorbing the money. Legal, healthcare, insurance and construction together capture roughly 72 percent of all disclosed vertical AI funding, from a little over half the deal volume.
Legal is the fastest riser. Legal AI companies have raised about $1bn year to date in 2026, with deal counts close to tripling.
Healthcare leads on volume, not share. It has the most disclosed rounds, 25 so far in 2026, but its share of capital has fallen from 56.7 percent to 27.1 percent as the category matures.
Insurance and construction are accelerating, with more deals and more new companies than in previous years.
Market size does not explain it. Healthcare has a larger addressable market than legal services. Retail and e-commerce are larger still. The capital goes to these four anyway.
How it works
In regulated work, an AI error is a legal event, not an inconvenience. It can trigger lawsuits, regulatory investigations, licence suspensions, lost insurance cover, and in medicine, harm to patients.
Every failure has a named owner. A diagnostic tool misses a condition and the provider faces malpractice. A contract reviewer hallucinates a clause and the firm faces sanctions. An underwriting model discriminates or under reserves and the insurer answers to state regulators. A construction workflow causes claims to go unpaid and the firm loses both cover and business.
So the product has to answer the liability question before the efficiency question. The companies attracting capital have built compliance teams, system architecture and carrier relationships that move risk onto a party able to absorb it.
The valuations follow that, not the model quality. Harvey tripled from $3bn to $5bn in months and reached $190mn in annual recurring revenue by late 2025. Abridge carries a $5.3bn valuation for automating clinical documentation, a narrow workflow with malpractice consequences if it goes wrong. Oscar Health has raised $1.63bn across 10 rounds.
Why it matters
Insurance carriers have become the gatekeepers. They now explicitly underwrite AI risk, are creating policy categories for AI errors, and demand governance frameworks before they will cover a deployment.
Procurement has a new mandatory gate. The old question was whether the technology worked. The new one is "can we get insured for this". If the answer is no, the deployment does not happen, however good the software.
Designing for insurability is now a fundraising advantage. XBuild raised a $19mn Series A for AI estimating built to generate exactly the documentation carriers need, having processed over $250mn in construction volume and automated more than 40,000 hours of manual estimation since launching in 2025. Shepherd raised $42mn in Series B underwriting construction insurance with agents that pull from project management software.
The scarce hire has changed. Domain experts, meaning lawyers, doctors, actuaries and construction project managers, are harder to recruit than machine learning engineers. A construction tech company needs someone who understands construction insurance, not only someone who knows PyTorch.
Exits now turn on regulatory questions. Will an acquirer inherit liability by integrating this system. Will the buyer's malpractice cover extend to the target's AI workflows. Those questions are reshaping valuations.
The moats are regional, not global. Liability frameworks differ by jurisdiction, so a legal AI product built for US contract law meets different assumptions in the UK, the EU or Singapore.
Carriers are becoming competitors. Munich Re, Travelers and major health insurers are investing in AI startups inside their own verticals.
What to do about it
Solve liability before efficiency. Customers value the time AI saves, but they will not accept new exposure to buy it. Build blame assignment into the architecture rather than bolting it on as a feature.
Learn the insurance requirements before the first deal. Talk to carriers, find out what documentation and governance they demand, then design the product to produce it automatically. The goal is to answer "can we get insured for this" with the policy language already in hand.
Create a paper trail. Healthcare buyers need cleared or cleared-equivalent systems. Law firms need evidence of attorney oversight. Underwriters need human review above defined thresholds. Construction firms need audit trails an insurer can verify.
Sell to the risk team, not just the buyer. The customer's broker is now part of your sales process and their compliance officer is your champion. Give them the documents they need to get sign off.
The honest catch
This is an argued thesis, and it is worth reading as one.
It is correlation, not a measured cause. The concentration in the disclosed data is real. Liability is a persuasive explanation for it, but not a proven one, and cheaper explanations exist, including high contract values and slow incumbents.
The numbers come from aggregators. Undisclosed rounds are missing, and trackers define "vertical AI" differently, so the shares move depending on who is counting.
Valuations are private marks, not exits. A $5bn figure is the result of a negotiation, not a realised outcome.
The thesis flatters the funded. Heavy compliance requirements protect companies that already have compliance teams and carrier relationships, and raise the barrier for smaller entrants. That is a moat for incumbents before it is a benefit to customers.
EDITOR'S TAKE
For a decade the industry told itself data was the moat: better training data, better model, defensible position. The vertical AI boom has shown that to be about half right. Domain data helps, but what is actually proving durable is institutional trust around who carries the blame, expressed as carrier relationships, governance frameworks and documentation. The useful test for any vertical AI pitch is simple. Ask what happens when the model is wrong, and see whether the answer is a paragraph about accuracy or a name. The strongest companies in these four sectors can point at a party that has agreed to absorb the risk, and that is harder to copy than a model.
Quick questions
Why are just four sectors taking most of the vertical AI money?
Legal, healthcare, insurance and construction capture roughly 72 percent of disclosed vertical AI funding while accounting for a little over half the deals. Market size does not explain it, because healthcare has a bigger addressable market than legal services and retail is larger than both. The common factor is regulation. In these four sectors an AI error is a legal event with a named owner: a malpractice claim, a disciplinary charge, a regulatory investigation, or lost insurance cover. That makes buyers willing to pay a premium for a system that moves the blame somewhere it can be absorbed, and investors treat that willingness as durable demand. The caveat is that this is an interpretation of the pattern rather than a proven cause.
What does it mean to design an AI product to be insurable?
It means building the evidence an insurance carrier needs directly into the product, rather than producing it later on request. In practice that is automatic audit trails, records of human review at defined decision thresholds, governance documentation, and integration with the systems carriers already use. XBuild is the clearest example: its estimating platform was built from launch to generate the documentation carriers want and to shift risk toward a shared data pool rather than the individual contractor. The commercial reason is that procurement now includes an insurance gate. If a buyer cannot get cover for a deployment, the deployment does not happen, no matter how good the technology is.
Is data no longer a moat in AI?
Data still helps, but on this evidence it is not sufficient on its own. The decade-long assumption was that proprietary training data produced better models and therefore a defensible position. In vertical AI the companies commanding the highest valuations are not obviously the ones with the best models. They are the ones that answered the liability question first and built the compliance teams, carrier relationships and documentation to prove it. Those relationships take years to assemble and cannot be scraped or bought quickly, which is what makes them defensible. Worth remembering that this argument also suits the already funded, since heavy compliance requirements raise the barrier for smaller entrants.
Sources
Crunchbase News: billion dollar AI fundraising and where the capital is landing.
New Market Pitch: vertical AI funding trends, deal lists and sector share analysis.
CRV: what vertical AI is and which companies are being backed.
Axios Pro: Shepherd's $42mn round for AI-underwritten construction insurance.
Law360: insurtech funding holding as AI deals dominate.
Value Add VC: health insurance AI startups underwriting risk differently.
Pulseline: the agent wave and why vertical AI is absorbing it.
Frontier Signal explains frontier technology in plain English. Funding figures are drawn from aggregators and disclosed rounds and should be verified against company releases. This is general information, not investment, legal or insurance advice.
